Prudential Financial’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.67M Sell
154,010
-63,870
-29% -$1.11M ﹤0.01% 1243
2025
Q1
$4.77M Buy
217,880
+19,820
+10% +$433K 0.01% 859
2024
Q4
$6.32M Sell
198,060
-89,700
-31% -$2.86M 0.01% 786
2024
Q3
$8.3M Buy
287,760
+42,500
+17% +$1.23M 0.01% 758
2024
Q2
$9.41M Sell
245,260
-300
-0.1% -$11.5K 0.01% 666
2024
Q1
$14.4M Sell
245,560
-81,000
-25% -$4.76M 0.02% 556
2023
Q4
$19.5M Buy
326,560
+23,000
+8% +$1.38M 0.03% 453
2023
Q3
$12M Buy
303,560
+126,480
+71% +$5.02M 0.02% 585
2023
Q2
$16.1M Sell
177,080
-259
-0.1% -$23.6K 0.02% 502
2023
Q1
$11.7M Sell
177,339
-42
-0% -$2.77K 0.02% 594
2022
Q4
$9.17M Sell
177,381
-3,993
-2% -$206K 0.02% 662
2022
Q3
$12.4M Buy
181,374
+13,744
+8% +$937K 0.02% 571
2022
Q2
$7.58M Sell
167,630
-164,572
-50% -$7.44M 0.01% 754
2022
Q1
$16.9M Buy
332,202
+151,932
+84% +$7.72M 0.02% 552
2021
Q4
$8.74M Buy
180,270
+8,875
+5% +$430K 0.01% 764
2021
Q3
$5.65M Sell
171,395
-12,745
-7% -$420K 0.01% 935
2021
Q2
$11.6M Buy
184,140
+19,180
+12% +$1.21M 0.02% 711
2021
Q1
$7.08M Buy
164,960
+200
+0.1% +$8.58K 0.01% 896
2020
Q4
$9.43M Buy
164,760
+40,490
+33% +$2.32M 0.02% 763
2020
Q3
$3.75M Buy
124,270
+35,016
+39% +$1.06M 0.01% 1030
2020
Q2
$2.92M Buy
89,254
+792
+0.9% +$25.9K 0.01% 1176
2020
Q1
$2.37M Buy
88,462
+15,966
+22% +$428K 0.01% 1284
2019
Q4
$2.22M Sell
72,496
-35,364
-33% -$1.08M ﹤0.01% 1551
2019
Q3
$2.63M Sell
107,860
-27,220
-20% -$664K ﹤0.01% 1445
2019
Q2
$3.42M Sell
135,080
-23,860
-15% -$605K 0.01% 1327
2019
Q1
$3.1M Sell
158,940
-64,320
-29% -$1.25M 0.01% 1364
2018
Q4
$2.96M Buy
223,260
+39,130
+21% +$518K 0.01% 1325
2018
Q3
$3.27M Buy
184,130
+49,230
+36% +$875K ﹤0.01% 1387
2018
Q2
$2.97M Buy
+134,900
New +$2.97M ﹤0.01% 1454